East Coast Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229K Hold
8,141
0.08% 61
2025
Q4
$203K Hold
8,141
0.06% 69
2025
Q3
$207K Buy
+8,141
New +$201K 0.07% 68
2025
Q2
Sell
-8,741
Closed -$221K 72
2025
Q1
$221K Hold
8,741
0.08% 67
2024
Q4
$232K Hold
8,741
0.08% 66
2024
Q3
$253K Hold
8,741
0.08% 65
2024
Q2
$245K Sell
8,741
-132
-1% -$3.63K 0.09% 64
2024
Q1
$246K Sell
8,873
-580
-6% -$16.1K 0.09% 63
2023
Q4
$272K Buy
9,453
+107
+1% +$3.23K 0.11% 59
2023
Q3
$310K Buy
9,346
+5
+0.1% +$177 0.14% 52
2023
Q2
$343K Sell
9,341
-283
-3% -$11K 0.15% 51
2023
Q1
$393K Buy
9,624
+5
+0.1% +$216 0.17% 48
2022
Q4
$493K Buy
9,619
+3
+0% +$144 0.25% 39
2022
Q3
$421K Buy
9,616
+4
+0% +$194 0.24% 41
2022
Q2
$504K Buy
9,612
+3
+0% +$153 0.24% 38
2022
Q1
$497K Buy
9,609
+4
+0% +$208 0.12% 41
2021
Q4
$567K Buy
9,605
+3
+0% +$149 0.13% 41
2021
Q3
$413K Sell
9,602
-541
-5% -$24K 0.1% 46
2021
Q2
$397K Buy
10,143
+464
+5% +$18K 0.09% 48
2021
Q1
$351K Sell
9,679
-395
-4% -$14K 0.09% 48
2020
Q4
$371K Sell
10,074
-540
-5% -$19.8K 0.11% 47
2020
Q3
$370K Sell
10,614
-7,168
-40% -$251K 0.13% 45
2020
Q2
$552K Buy
17,782
+5
+0% +$170 0.16% 40
2020
Q1
$551K Sell
17,777
-1,813
-9% -$61.8K 0.21% 37
2019
Q4
$728K Buy
19,590
+5
+0% +$178 0.2% 41
2019
Q3
$668K Buy
19,585
+35
+0.2% +$1.27K 0.19% 44
2019
Q2
$803K Buy
19,550
+121
+0.6% +$4.8K 0.21% 40
2019
Q1
$783K Sell
19,429
-1,656
-8% -$66.3K 0.19% 44
2018
Q4
$873K Sell
21,085
-822
-4% -$34.1K 0.27% 38
2018
Q3
$916K Sell
21,907
-606
-3% -$23.3K 0.24% 42
2018
Q2
$775K Sell
22,513
-3,055
-12% -$104K 0.21% 45
2018
Q1
$861K Sell
25,568
-19,484
-43% -$670K 0.25% 44
2017
Q4
$1.55M Sell
45,052
-11,240
-20% -$383K 0.42% 35
2017
Q3
$1.91M Sell
56,292
-4,068
-7% -$131K 0.5% 31
2017
Q2
$1.92M Sell
60,360
-2,684
-4% -$84.6K 0.53% 32
2017
Q1
$2.05M Buy
63,044
+1,085
+2% +$34.2K 0.56% 30
2016
Q4
$1.91M Sell
61,959
-602
-1% -$18.4K 0.57% 30
2016
Q3
$2.01M Sell
62,561
-176
-0.3% -$5.88K 1.04% 30
2016
Q2
$2.1M Sell
62,737
-8,552
-12% -$273K 1.15% 28
2016
Q1
$2M Sell
71,289
-1,098
-2% -$31.4K 1.06% 34
2015
Q4
$2.22M Sell
72,387
-256
-0.4% -$8.05K 1.22% 29
2015
Q3
$2.17M Sell
72,643
-1,134
-2% -$36.4K 1.35% 32
2015
Q2
$2.35M Sell
73,777
-41
-0.1% -$1.34K 1.25% 35
2015
Q1
$2.44M Buy
73,818
+2,832
+4% +$90K 1.29% 35
2014
Q4
$2.1M Buy
70,986
+72
+0.1% +$2.06K 1.15% 35
2014
Q3
$1.99M Buy
70,914
+776
+1% +$21.8K 1.14% 38
2014
Q2
$1.98M Sell
70,138
-330
-0.5% -$9.41K 1.09% 38
2014
Q1
$2.15M Buy
70,468
+1,409
+2% +$42K 1.25% 35
2013
Q4
$2.01M Buy
69,059
+2,546
+4% +$74.1K 1.17% 35
2013
Q3
$1.81M Sell
66,513
-5,563
-8% -$151K 1.19% 36
2013
Q2
$1.92M Buy
+72,076
New +$1.99M 1.04% 32

Other funds holding PFE

East Coast Asset Management's PFE Position: Q1 2026 in Review

East Coast Asset Management held its Pfizer (PFE) position steady in Q1 2026 at 8,141 shares worth $229K. The position accounts for 0.08% of the portfolio, ranked #61.

East Coast Asset Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.44M in Q1 2015. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • East Coast Asset Management held 8,141 shares of Pfizer worth $229K as of Q1 2026.
  • East Coast Asset Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.08% of East Coast Asset Management's portfolio in Q1 2026, its #61 holding.
  • East Coast Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • East Coast Asset Management's Pfizer position peaked at $2.44M in Q1 2015.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on East Coast Asset Management's 13F filing for Q1 2026, filed 15 May 2026.